What is medication-assisted treatment for alcohol use?

Medication-assisted treatment is a plain phrase for a simple idea: using an FDA-approved prescription medication, alongside some kind of behavioral support, to help someone drink less or stay stopped. The medication is not the whole plan, and it is not a sedative that gets you through a rough night. It is a tool that changes how your brain responds to alcohol over weeks and months. The useful question is not what the phrase means in the abstract but what the medications actually do differently — because there are three approved for alcohol, and they do genuinely different jobs.

What the three medications actually do

Start with the reward. A drink gives most people a small lift, and that lift is part of what makes the next drink appealing. Naltrexone works on that. It blocks the brain's opioid receptors — the same signaling the body uses for its own feel-good chemistry — so a drink gives less of a lift, and the pull toward the next one eases with it. The American Academy of Family Physicians puts it plainly: those receptors help produce the pleasant effects of alcohol, and blocking them makes drinking less reinforcing. The FDA label lists naltrexone for alcohol dependence, and it can be considered while someone is still drinking, which is part of why it comes up so often.

Acamprosate takes a different route entirely. Drink heavily for months or years and the brain resets itself around the constant chemical tilt; take the alcohol away and that reset is still there, so early sobriety can feel restless, wired, and raw. In the pharmacology literature, acamprosate is described as working on that over-revved system to help it settle back toward normal. It leaves the reward alone. That is also why it is approved to help people who have already stopped stay stopped, rather than to help someone cut down mid-drink.

Disulfiram is the odd one out, and deliberately so. Instead of touching cravings, it works like a tripwire. The FDA label explains that it blocks a step your body uses to break alcohol down, so a byproduct called acetaldehyde piles up — and drinking on it makes you feel genuinely ill. It is described as an aid for someone who wants to stay in a state of enforced sobriety, and the label is blunt that it is not a cure. It only helps if the person actually takes it.

So three tools, three jobs, as one peer-reviewed overview lays them out: naltrexone turns down the reward, acamprosate steadies an off-balance brain after quitting, and disulfiram makes drinking unpleasant. The rest of the decision — which one, if any — runs off that.

What the evidence supports, and where it stops

None of these are equally studied. When the federal Agency for Healthcare Research and Quality (AHRQ) reviewed the outpatient trials, it found the strongest support behind naltrexone and acamprosate for reducing a return to drinking, and rated the evidence for disulfiram against a placebo inadequate — largely because in blinded trials people knew whether they might get sick, and the deterrent only works when you believe it is there. That does not make disulfiram useless; it makes it a specific tool for a specific situation.

The other thing every authoritative list agrees on is that the medication is meant to sit next to support, not replace it. The AAFP recommends pairing any of these with behavioral help rather than using it alone, and the World Health Organization describes drugs like naltrexone as working best as an adjunct given alongside psychosocial treatment. The medication changes the chemistry; the support changes the habits built on top of it.

A fourth name now turns up in this conversation, and it sits in a different category from the three above. GLP-1 medications — the class that includes semaglutide, sold as Ozempic and Wegovy for diabetes and weight management — copy a gut hormone that tells the brain you have had enough, and some people taking them began reporting, unprompted, that they wanted alcohol less. Researchers followed that up. The National Institutes of Health summarized a randomized trial in which adults who had both alcohol use disorder and obesity cut back on heavy drinking when semaglutide was added to cognitive behavioral therapy — a structured form of talk therapy — compared with the same therapy plus a placebo. One trial, in one specific group of people, is a starting point rather than a settled answer, and none of these medications is FDA-approved for alcohol use disorder — using one for drinking is off-label, meaning outside its approved uses. Treat it as research worth watching, and worth raising with a clinician if a GLP-1 is already in your health picture for another reason.

Here is where the evidence runs out. It can tell you these options exist, roughly how well each is supported, and what each is built to do. It cannot tell you which one fits you. Drinking history, kidney and liver health, other medications, mental health, past withdrawal, and — critically for naltrexone — any opioid use all change the picture, and some of them rule an option in or out. Naltrexone, for instance, is not compatible with opioid pain medication or opioid dependence, because it can force sudden withdrawal. That is a clinical judgment, not a search-result judgment.

The gap worth naming

In 2024, an estimated 27.9 million people ages 12 and older in the United States had past-year alcohol use disorder, per NIAAA — about 9.7% of that age group. Yet only about 2.1 million of them received any alcohol-use treatment that year, roughly 7.6%. That is not evidence the medicines fail. It mostly means the conversation never happens — most people never see a clinician who raises it. So if you are reading this at all — whether it is for you or for someone you love — you are already doing the uncommon part.

What to do with this

A few concrete moves, depending on where you are starting:

• Name the goal before the medication. Wanting to cut back and wanting to stop completely point toward different conversations — acamprosate is built around staying off alcohol, while naltrexone can be discussed while you are still drinking. Saying the goal plainly lets a clinician match the tool to it, instead of the reverse.
• Write down the real drinking picture. How much, how often, how long, and what a stretch without alcohol has felt like. A clinician weighing these options needs an honest number more than a rounded-down one, and past withdrawal history in particular changes what is safe. If you want a reference point for the word heavy, NIAAA counts 5 or more drinks on any day or 15 or more in a week for men, and 4 or more on any day or 8 or more in a week for women.
• Treat "which is best" as the wrong question. The sharper one is which option is worth discussing first given your goal and history — and if the first does not fit, that is not the end of it.

When it is a clinician's call, and when it is an emergency

The medication decision belongs with a licensed clinician who can review your history — that is the whole point of the safety questions above. If the drinking is heavy and daily, one more question belongs in that appointment: whether medically supervised withdrawal, or a higher level of care than an outpatient prescription, should come first. A pill is one rung on a ladder that also includes supervised detox, day programs, and inpatient care, and which rung fits is a clinical judgment. Pharmacists are a legitimate stop too, for the practical questions a prescriber may not have time for — what to take a medication with, what to do about a missed day.

If you do not have anyone to start the conversation with, Clero connects you with a licensed clinician by telehealth to talk through whether a medication like naltrexone fits your situation.

One thing medication-assisted treatment is not built for is getting through withdrawal itself. Stopping suddenly after heavy daily drinking can be genuinely dangerous, so that is a plan to make with a clinician, not alone. If a stretch without alcohol has ever brought on shaking, confusion, hallucinations, or a seizure, treat it as a medical emergency — call 911 or go to an emergency room. If you are having thoughts of harming yourself, call or text 988.

The clearest way to leave this page: medication is one real, mainstream part of treating alcohol use disorder, the three approved options do different things, and matching one to a person is a decision the evidence sets up but cannot make for you.

This article is general education — not medical advice, a dosing guide, or a prescription. Any decision about medication is one to make with a licensed clinician who knows your history; for confidential treatment referrals you can also reach SAMHSA's helpline at 1-800-662-HELP.

Coming soon

Want the private naltrexone update?

Join the launch list to hear first. Today, this is still educational content, not a prescription request or clinical intake.

Get the naltrexone updateNot a prescription request, not medical advice, and not available for treatment today.